ArticleAmerican journal of cancer research2023

Temozolomide combined with ipilimumab plus nivolumab enhances T cell killing of MGMT-expressing, MSS colorectal cancer cells.

Zenovia Gonzalez et al.PubMed ↗Full text ↗

No numbers read from the abstract.